SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001437749-24-032144
Filing Date
2024-10-25
Accepted
2024-10-25 16:43:52
Documents
6
Effectiveness Date
2024-10-25

Document Format Files

Seq Description Document Type Size
1 FORM S-8 mbrx20241022_s8.htm S-8 67895
2 EXHIBIT 5 ex_737266.htm EX-5 7810
3 EXHIBIT 23.1 ex_736270.htm EX-23.1 2298
4 EXHIBIT 99.1 ex_736276.htm EX-99.1 89623
5 EXHIBIT 99.2 ex_736281.htm EX-99.2 88774
6 EXHIBIT FILING FEES ex_736271.htm EX-FILING FEES 15102
  Complete submission text file 0001437749-24-032144.txt   272529
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671997 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-282838 | Film No.: 241397556
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)